Myocardial Infarction

27 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Cardiovascular Diseases, Heart Diseases

Narrower: Anterior Wall Myocardial Infarction 1, Non-ST Elevated Myocardial Infarction 5, Shock, Cardiogenic 1, ST Elevation Myocardial Infarction 10

Treatments and conditions

Myocardial Infarction
Treatment and conditionWhere it standsTrials
Acetylcysteine for st elevation myocardial infarctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Atorvastatin for myocardial infarctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Canakinumab for myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cardiovascular Polypill for myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cholecalciferol for myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Clopidogrel for myocardial infarctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Colchicine for myocardial infarctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Combined antioxidant therapy for st elevation myocardial infarctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Direct oral anticoagulant for st elevation myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Evolocumab for non-st elevated myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Evolocumab for st elevation myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Impella 5.5 for shock, cardiogenicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Inclisiran for non-st elevated myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Inclisiran for st elevation myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
PolyPill for non-st elevated myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
PolyPill for st elevation myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Recombinant Human Thymosin Beta 4 Injection (NL005) for anterior wall myocardial infarctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Recombinant Human Thymosin Beta 4 Injection (NL005) for st elevation myocardial infarctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Recombinant varicella zoster virus glycoprotein e antigen for myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tenecteplase for st elevation myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ticagrelor for myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ticagrelor for non-st elevated myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ticagrelor for st elevation myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Ticagrelor + placebo for non-st elevated myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ticagrelor + placebo for st elevation myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
VERVE-102 for myocardial infarctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ziltivekimab for myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.